(Q44661684)
Statements
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance (English)
Sami Joha
Sélim Corm
Jean-Luc Laï
Isabelle Tigaud
Franck-Emmanuel Nicolini
Fi-LMC group
Nathalie Philippe
Sandrine Geffroy
17 January 2008